January 27, 2021

Volume XI, Number 27

Advertisement

January 27, 2021

Subscribe to Latest Legal News and Analysis

January 26, 2021

Subscribe to Latest Legal News and Analysis

January 25, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
17
Dec
FTC Cracks Down on Health Claims by CBD Companies Squire Patton Boggs (US) LLP
17
Dec
EEOC Updates COVID-19 Guidance on Employer Administered or Mandated Vaccinations Epstein Becker & Green, P.C.
17
Dec
“Bee Better Certified™ Seal” That Tells Consumers Certified Ingredients Are Grown in Ways That Support Bees Gains Traction Keller and Heckman LLP
17
Dec
FDA Issues New Guidance on Drug Naming Mintz
16
Dec
China Solicits Comments on Food-Contact Substances December 16, 2020 Keller and Heckman LLP
16
Dec
When Can Hospitals Be Subjected to Strict Product Liability? The Connecticut Supreme Court Is Mulling It Over. Wiggin and Dana LLP
16
Dec
Proposed Class Sues Cheese Producer Over Smokey Flavor Labeling Keller and Heckman LLP
16
Dec
Hemp Suits: Proactive Risk Management is Key Ward and Smith, P.A.
15
Dec
New York Bans PFAS in Food Packaging Keller and Heckman LLP
15
Dec
FDA in 2020: What a Year! Mintz
15
Dec
California Moves for Summary Judgment Against Mikoyo on Claims Related to Marketing of Plant-Based “Butter” Keller and Heckman LLP
15
Dec
Supreme Court Rules that ERISA Does Not Preempt State Law Regulating PBM Reimbursements Robinson & Cole LLP
15
Dec
HRSA Publishes Long-Awaited 340B Program Administrative Dispute Resolution Procedures Dinsmore & Shohl LLP
15
Dec
New HHS Board Will Hear 340B Drug Pricing Disputes Foley & Lardner LLP
14
Dec
Second Circuit Affirms Mirena MDL Court’s “Hard Look” at Plaintiffs’ Experts’ Methodology Faegre Drinker
14
Dec
U.S. Supreme Court: State Law Regulating Pharmacy Benefit Managers is Not Preempted by ERISA Jackson Lewis P.C.
14
Dec
USDA Will Prohibit the Statements “No Nitrate or Nitrite Added” and “Uncured” on Products That Have Been Processed Using Any Source of Nitrates or Nitrites Keller and Heckman LLP
12
Dec
COVID-19 Weekly Newsletter: FDA Committee Recommends Vaccine Approval Faegre Drinker
11
Dec
HRSA Publishes Long-Awaited (and Long-Overdue) 340 B Program Alternative Dispute Resolution Process Final Rule K&L Gates
11
Dec
Pennsylvania’s COVID Christmas Closure 2020 Norris McLaughlin P.A.

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement